Heidelberg Pharma Receives Milestone Payment from Partner Magenta
Heidelberg Pharma AG announced today that it has received a milestone payment from its cooperation partner Magenta Therapeutics, Cambridge, MA, USA, (Magenta) associated with the initiation of the GLP toxicology study for the development candidate MGTA-117.